Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients
Status:
Completed
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a long-term prophylactic use of
esomeprazole 20 mg twice daily or once daily has prevention effectiveness in reducing the
recurrence of peptic ulcer bleeding after ulcer healed with 16-week oral esomeprazole therapy
in high-risk patients whose Rockall score ≥ 6.